Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Hematologic Tests × Clear all

NCT03568188 2026-02-24

FOCALE

Phase 2 Completed

Prostatic Neoplasms

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

22 enrolled 14 charts

Prostatic Neoplasms